プレゼンテーションのダウンロード(ppt form) - P-drug

Download Report

Transcript プレゼンテーションのダウンロード(ppt form) - P-drug

医学教育とPersonal drugの考え
方:今後の展望
第34回日本医学教育学会大会ミニ・シンポジウム
昭和大学, 東京, 2002.1.26(土)
東京大学大学院薬学系研究科医薬経済学
津谷喜一郎
W
WHY WHAT
H
O
HO
WHERE
N
History of the Guide to Good Prescribing
1991-1992
1994
Training courses
Global field test
Guide to Good Prescribing
Groningen (1995-2000)
Cape Town (1996,1997, 2000)
La Plata (1999, 2000, 2001)
Manila (2001)
Current languages
Albanian, Arabic, Bengali, Bosnian, Catalan, Chinese,
English, French, German, Indonesian, Italian, Japanese,
Portuguese, Romanian, Russian, Serbian, Slovakian, Spanish,
Turkish, Vietnamese
RCT on P-drug training
• Participants: 219 medical students in
Groningen , Kathmandu, Lagos, Newcastle,
New Delhi, San Francisco, Yogyakarata
• outcome: positive retention effect and
transfer effect after six month
de Vries TPGM, Henning RH, Hogerzeil HV, et.al. Impact of a short
course in pharmacotherapy for undergraduate medical students: an
international randomised controlled study. Lancet 1995: 346:1454-7
[email protected]
National courses
Who train whom ? present and future
Who are trainers ?
P-NET-J
⇒ P-NET-J +
Who are trainees ?
Those who have interest/motivation
outside university
⇒ Medical /pharmaceutical students in
the university
Why ?
“Irrational prescribing is a habit
which is difficult to cure”
de Vries TPGM, Henning RH, Hogerzeil HV, et.al. Impact of a short
course in pharmacotherapy for undergraduate medical students: an
international randomised controlled study. Lancet 1995: 346:1454-7
薬の選択:薬籠に何を入れる
か
第6回日本薬剤疫学会シンポジウムII
2000.11.11(土),東京
オーガナイザー・座長
東京医科歯科大学
津谷喜一郎
1. WHO必須医薬品モデルリストの作り方
京大・臨床疫学・福井次矢
2. 日本で使われる薬の数と承認の考え方
(財)医療機器センター・久保田晴久
3. 病院医薬品集(Hospital Formulary)の実態
帝京大・市原病院・薬・清水秀行、他
4. P-drugの考え方と実際
昭和大学・薬理・内田英二
( 臨床薬理 2001; 28(3): 497-525)
エッセンシャルドラッグとパーソナルド
ラッグ
公開セミナー, 東京大学, 2002.1.26(土)
1. E-drugとP-drug:セミナーの趣旨
津谷喜一郎
2. 「EBMに基づいた必須医薬品リスト選定のガイドライン作成に関する
調査」班活動について
3. P-drugの日本での展開
4. 薬学におけるP-drug教育
浜松医科大学臨床薬理学
渡辺裕司
昭和大学第2薬理学
内田英二
富山医科薬科大学薬剤部
川上純一
5. WHOエッセンシャル・ドラッグ・モデルリストは先進国において意味
が あるか? WHO Essential Drug List 担当医官
Hans Horgerzeil
6. 「内科医の薬100」 作成のコンセプトと実際 東海大学医学部 上野文昭
7. 米国HMOの現状
岡山大学大学院医療経済学
西田在賢
8. Panel discussion
「薬理と治療」誌収載予定,2002
Future
•
•
•
•
•
•
•
•
Marketing approval
Reimbursement package
Formula
Training
Core curriculum of medical training
Clinical Practice Guidelines
Decision making support system (Library)
“Teachers manual”
The WHO Essential Medicines Library
to facilitate the work of national committees
Clinical
guideline
Evidence:
- Reasons for inclusion
- Systematic reviews
- Key references
Cost:
- per unit
- per treatment
- per month
- per case prevented
Summary of clinical
guideline
WHO Model
Formulary
WHO
Model List
Quality information:
- Basic quality tests
- Intern. Pharmacopoea
- Reference standards
Teacher’s Guide to Good Prescribing
Overview (1)
Part 1: How to teach pharmacotherapy
with the GGP
•
•
•
•
•
•
The role of the teacher
How to formulate learning objectives
How to make good patient examples
Teaching notes to each chapter
Developing critical appraisal skills
Application in primary care settings
Teacher’s Guide to Good Prescribing
Overview (2)
Part 2: How to assess students, teachers
and the course
• How to assess the students
• How to assess the teachers
• How to assess the impact of the training
Part 3: How to mobilise support
• How to mobilise support for problembased pharmacotherapy teaching